Recombinant DNA technology - or gene engineering - has progressed dramatically in the past decade to the point where it now represents 98 per cent of all fertility drugs prescribed in the US.
Recombinant DNA technology - or gene engineering - has progressed dramatically in the past decade to the point where it now represents 98 per cent of all fertility drugs prescribed in the US.